Brooks is selling the division to Thomas H. Lee Partners for $3 billion.
Collaborative robotic provider, Agile Robots, closes a $220M Series C round – to enable the company to extend its product and expand its global market reach.
Flow Robotics launches flowbot ONE in North America, to help automate lab testing and automation of diagnostic protocols.
A computer model relates a finger’s desired position to the corresponding pressure a pump would have to apply to achieve that position. Using this model, the team developed a controller that directs the pneumatic system to inflate the fingers.
Memic develops Hominis, the first FDA-approved, robotically-assisted surgical device for performing transvaginal hysterectomy.
Myomo recognized revenue on 80 units in the second quarter, an increase of 233% compared with the second quarter of 2020.
Rani developed a proprietary platform, RaniPill, designed to provide a pill-based alternative to intravenous or subcutaneous administration of biologics.
We also discuss on the podcast the future of Fetch Robotics after the Zebra acquisition, Aurora taking its self-driving tech public via SPAC, the shutdown of Abundant Robotics and more.
A women was a candidate for a free-flap reconstruction to save the arm after amputation after a motorcycle accident.
The benefits of minimally-invasive surgery have been recognized for decades, but adoption in the spine market has been slow compared to other procedures.
Micromate uses a universal instrument guidance platform that allows physicians to continue using their preferred surgical instruments while performing targeting under live imaging.
AquaBeam is an image-guided robotic system for use in minimally-invasive urologic surgery.
NuVasive said clinical evaluations for Pulse are now underway across multiple countries throughout Europe.
CMR Surgical has now raised nearly $1 billion since it was founded in 2014.
The procedure marks the beginning of the Hugo system patient registry, which will collect clinical data as Medtronic seeks regulatory submissions.
Memic develops Hominis, the first FDA approved, robotically-assisted surgical device for transvaginal hysterectomies.
The race was on – safely – for more than 50,000 spectators Saturday at the 147th Kentucky Derby in part thanks to Pittsburgh-based AERAS. The company used its patented charged-electrostatic drone technology to sanitize Churchill Downs against COVID-19. This in part helped allow fans to return to the oldest sporting event in the United States.…
Multiply Labs, a San Francisco-based company developing automated manufacturing systems to produce individualized drugs at scale, raised $20 million in a Series A funding. The round was led by Casdin Capital. The oversubscribed round brings Multiply Labs’ total funding raised to date to more than $25 million. It leverages automation to address the fundamental limitations…
Memic Innovative Surgery closed a $96 million Series D financing round. The Tel Aviv, Israel-based company develops Hominis, the first FDA-approved robotically-assisted surgical device for performing transvaginal hysterectomy. The FDA approved the Hominis system last month. Hominis is designed to remove the uterus using minimally invasive surgical instruments inserted through the vagina, as well as…
Robotics researchers are developing exoskeletons and prosthetic legs capable of making control decisions on their own using sophisticated artificial intelligence (AI) technology. The system combines computer vision and deep learning to mimic how able-bodied people walk by seeing their surroundings and adjusting their movements. “We’re giving robotic exoskeletons vision so they can control themselves,” said…
Exoskeleton users can now go from sitting to standing safely and without assistance based on the work of University of Michigan researchers, who developed an approach to create and test solutions to such problems virtually.
Forsight Robotics, an Israel-based developer of a robotic surgical platform for ophthalmic procedures, has raised $10 million. The seed round was led by Eclipse Ventures and joined by Mithril Capital. The funding is earmarked to be used for expanding ForSight’s headcount and global reach as it sets its sights on launching its robotic surgery platform…